Cargando…

Molecular prognostic factors in colorectal cancer: 5-year follow-up

Colorectal cancer (CRC) is a frequently diagnosed and lethal disease. The risk of developing CRC is determined by environmental and genetic factors. Surgical treatment is the main curative modality for patients with CRC up to stage III. In recent years, a special place has been given to biological a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciobanu, Alina Elena, Pîrvu, Daniel-Cristian, Mărginean, Cristina Maria, Dijmărescu, Anda Lorena, Muñoz-Groza, Adriana-Estefa, Meşină, Cristian, Bălşeanu, Tudor-Adrian, Băleanu, Vlad Dumitru, Ţenea-Cojan, Tiberiu Ştefăniţă, Ciobanu, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257784/
https://www.ncbi.nlm.nih.gov/pubmed/37128793
http://dx.doi.org/10.47162/RJME.64.1.08
_version_ 1785057365110816768
author Ciobanu, Alina Elena
Pîrvu, Daniel-Cristian
Mărginean, Cristina Maria
Dijmărescu, Anda Lorena
Muñoz-Groza, Adriana-Estefa
Meşină, Cristian
Bălşeanu, Tudor-Adrian
Băleanu, Vlad Dumitru
Ţenea-Cojan, Tiberiu Ştefăniţă
Ciobanu, Daniela
author_facet Ciobanu, Alina Elena
Pîrvu, Daniel-Cristian
Mărginean, Cristina Maria
Dijmărescu, Anda Lorena
Muñoz-Groza, Adriana-Estefa
Meşină, Cristian
Bălşeanu, Tudor-Adrian
Băleanu, Vlad Dumitru
Ţenea-Cojan, Tiberiu Ştefăniţă
Ciobanu, Daniela
author_sort Ciobanu, Alina Elena
collection PubMed
description Colorectal cancer (CRC) is a frequently diagnosed and lethal disease. The risk of developing CRC is determined by environmental and genetic factors. Surgical treatment is the main curative modality for patients with CRC up to stage III. In recent years, a special place has been given to biological agents used as targeted therapy following the genetic analysis of the tumor: Bevacizumab (Avastin), Cetuximab (Erbitux), Ziv-aflibercept (Zaltrap). We present a study based on 46 colorectal tumor resection specimens from patients operated for CRC in the Surgery Departments of the Emergency County Clinical Hospital of Craiova, Romania. Histopathological examination and immunohistochemistry staining of tissue sections were performed to determine the degree of aggressiveness. Using the Kaplan–Meier test, we calculated the correlation coefficient between survival time and immunohistochemical prognostic factors. The patients were followed for 60 months postoperatively.
format Online
Article
Text
id pubmed-10257784
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest
record_format MEDLINE/PubMed
spelling pubmed-102577842023-06-12 Molecular prognostic factors in colorectal cancer: 5-year follow-up Ciobanu, Alina Elena Pîrvu, Daniel-Cristian Mărginean, Cristina Maria Dijmărescu, Anda Lorena Muñoz-Groza, Adriana-Estefa Meşină, Cristian Bălşeanu, Tudor-Adrian Băleanu, Vlad Dumitru Ţenea-Cojan, Tiberiu Ştefăniţă Ciobanu, Daniela Rom J Morphol Embryol Original Paper Colorectal cancer (CRC) is a frequently diagnosed and lethal disease. The risk of developing CRC is determined by environmental and genetic factors. Surgical treatment is the main curative modality for patients with CRC up to stage III. In recent years, a special place has been given to biological agents used as targeted therapy following the genetic analysis of the tumor: Bevacizumab (Avastin), Cetuximab (Erbitux), Ziv-aflibercept (Zaltrap). We present a study based on 46 colorectal tumor resection specimens from patients operated for CRC in the Surgery Departments of the Emergency County Clinical Hospital of Craiova, Romania. Histopathological examination and immunohistochemistry staining of tissue sections were performed to determine the degree of aggressiveness. Using the Kaplan–Meier test, we calculated the correlation coefficient between survival time and immunohistochemical prognostic factors. The patients were followed for 60 months postoperatively. Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2023 2023-03-31 /pmc/articles/PMC10257784/ /pubmed/37128793 http://dx.doi.org/10.47162/RJME.64.1.08 Text en Copyright © 2023, Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited.
spellingShingle Original Paper
Ciobanu, Alina Elena
Pîrvu, Daniel-Cristian
Mărginean, Cristina Maria
Dijmărescu, Anda Lorena
Muñoz-Groza, Adriana-Estefa
Meşină, Cristian
Bălşeanu, Tudor-Adrian
Băleanu, Vlad Dumitru
Ţenea-Cojan, Tiberiu Ştefăniţă
Ciobanu, Daniela
Molecular prognostic factors in colorectal cancer: 5-year follow-up
title Molecular prognostic factors in colorectal cancer: 5-year follow-up
title_full Molecular prognostic factors in colorectal cancer: 5-year follow-up
title_fullStr Molecular prognostic factors in colorectal cancer: 5-year follow-up
title_full_unstemmed Molecular prognostic factors in colorectal cancer: 5-year follow-up
title_short Molecular prognostic factors in colorectal cancer: 5-year follow-up
title_sort molecular prognostic factors in colorectal cancer: 5-year follow-up
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257784/
https://www.ncbi.nlm.nih.gov/pubmed/37128793
http://dx.doi.org/10.47162/RJME.64.1.08
work_keys_str_mv AT ciobanualinaelena molecularprognosticfactorsincolorectalcancer5yearfollowup
AT pirvudanielcristian molecularprognosticfactorsincolorectalcancer5yearfollowup
AT margineancristinamaria molecularprognosticfactorsincolorectalcancer5yearfollowup
AT dijmarescuandalorena molecularprognosticfactorsincolorectalcancer5yearfollowup
AT munozgrozaadrianaestefa molecularprognosticfactorsincolorectalcancer5yearfollowup
AT mesinacristian molecularprognosticfactorsincolorectalcancer5yearfollowup
AT balseanutudoradrian molecularprognosticfactorsincolorectalcancer5yearfollowup
AT baleanuvladdumitru molecularprognosticfactorsincolorectalcancer5yearfollowup
AT teneacojantiberiustefanita molecularprognosticfactorsincolorectalcancer5yearfollowup
AT ciobanudaniela molecularprognosticfactorsincolorectalcancer5yearfollowup